Health And Medicine
-
Watch: Lab-to-Table Conversations: “The Science of Beer” featuring biochemistry faculty and beer science alumni
Vanderbilt alumni and the founders of Jackalope Brewing Co. and Yazoo Brewing Co. will join Vanderbilt researchers for a Dec. 16 virtual discussion about beer and fermentation science. Read MoreNov 30, 2021
-
Jon Kaas receives Society for Neuroscience’s highest honor for pathbreaking cerebral cortex research
Distinguished psychology professor Jon Kaas has received the Ralph W. Gerard Prize in Neuroscience, the highest recognition from the Society for Neuroscience, for his pathbreaking work in illuminating the structure and function of the cerebral cortex and plasticity in the developing and adult brain. Read MoreNov 23, 2021
-
Burkewitz awarded $100,000 to conduct longevity research at the cellular level
Kristopher Burkewitz, assistant professor of cell and developmental biology, has been awarded $100,000 from the American Federation for Aging Research and the Glenn Foundation for Medical Research to research the biological aging process. Read MoreNov 22, 2021
-
Five from VUMC among most highly cited researchers
Five Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers. Read MoreNov 18, 2021
-
Vanderbilt Nursing School informaticist receives $80,000 from the CDC to investigate nation’s PPE supply
Kelly Aldrich to lead year-long project modeling trends of hospital PPE. Read MoreNov 16, 2021
-
Learn about the science of longevity with Vanderbilt experts in virtual event
The School of Medicine Basic Sciences’ monthly Lab-to-Table Conversation will bring together research experts on Tuesday, Nov. 30, for a virtual discussion about our current understanding of the biology of longevity. Read MoreNov 15, 2021
-
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Stephen Fesik’s discovery of a cancer-targeting molecule has been made freely accessible through opnMe for global researchers to advance research into cancer therapeutics. Read MoreNov 15, 2021
-
CRISPR screen identifies new anti-inflammatory drug target
A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics. Read MoreNov 11, 2021
-
New way to bEET insulin resistance
Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered. Read MoreNov 11, 2021
-
The challenge of rejection
Minimizing variation in how rejection is diagnosed and creating standardized surveillance protocols may help inform best practices in pediatric heart transplants. Read MoreNov 10, 2021
-
VUMC researchers a step closer to broad ebolavirus protection
A combination of two broadly acting monoclonal antibodies isolated by researchers at Vanderbilt University Medical Center protected non-human primates from ebolavirus disease, which causes severe and often-fatal hemorrhagic fever in humans. Read MoreNov 10, 2021
-
Zost honored for research on COVID-19, other life-threatening viral diseases
Vanderbilt's Seth Zost, PhD, has been awarded a major international prize for his research on COVID-19 and other life-threatening viral diseases. Read MoreNov 10, 2021
-
Research Snapshot: New target identified for rapid antidepressant drugs
Vanderbilt researchers push research on ketamine’s role as a rapid antidepressant another step forward. This work opens avenues for new therapeutics for half of people for whom today’s antidepressants don’t work. Read MoreNov 10, 2021
-
Research Snapshot: Discovery shows how synapses are built and function in the nervous system
Discovering a signaling pathway’s influence on brain development in a nematode sheds light on human nervous systems. Est. reading time: 2 mins. Read MoreNov 8, 2021
-
$8 million NIH grant awarded to Vanderbilt researchers for study of infant/child brain development
Vanderbilt faculty members Laurie Cutting and Sarah Osmundson will lead an $8 million grant from the National Institutes of Health as part of a groundbreaking, multi-institutional overview of variables influencing infant and child brain development, including substance exposure. Read MoreNov 2, 2021
-
Uncovering how injury to the pancreas impacts cancer formation
Research from scientists at the School of Medicine Basic Sciences and the Salk Institute for Biological Studies shows that cells in the pancreas form new cell types to mitigate injury but are then susceptible to cancerous mutations. Read MoreOct 29, 2021
-
Research Snapshot: Eat breakfast and stop late-night snacking
Eating a larger, protein-filled breakfast is one of the best ways to maintain a healthy weight. A smaller but still significant change would be to avoid late-night snacking. Est. reading time: 3.5 mins. Read MoreOct 28, 2021
-
Research Snapshot: Professor discovers signaling pathway that lets ketamine act as a rapid antidepressant
Lisa Monteggia and her lab have identified how specific neurons in the hippocampus work to produce ketamine’s antidepressant action. Est. reading time: 2 mins. Read MoreOct 27, 2021
-
Research Snapshot: COVID-19 virus test sensitivity varies with body’s circadian rhythm
Carl Johnson, Cornelius Vanderbilt Professor of Biological Sciences and expert in biological clocks, identifies temporal component to COVID-19 viral shedding. Est. reading time: 2.5 mins. Read MoreOct 26, 2021
-
Global Vanderbilt: Carlos Lopez: “It’s beyond you’re welcome here, this is the place where you belong.”
Carlos Lopez, associate professor of biochemistry and biomedical informatics, describes how international faculty belong at Vanderbilt. Read MoreOct 21, 2021